Skip to Main Content

WASHINGTON — For the cadre of progressive groups fighting to bring down drug prices in a big way, this week was a massive setback.

The broad coalition, which includes consumer advocates, employers, and labor unions, was blindsided Wednesday when a trio of moderate House Democrats formally opposed Speaker Nancy Pelosi’s sweeping drug pricing package — a consequential move, since Democrats’ razor-thin majority means that even three opponents could force leadership to water down or abandon an otherwise popular policy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment